Other studies established that miR-29b modulated the global DNA methylation through targeting DNMT3A and DNMT1, leading to decreased transcription factor specificity protein 1 (SP1) and increased p21 expression in chronic lymphocytic leukemia (CLL) cells [104]. The gene discussed is DNMT3A; the disease is B-cell chronic lymphocytic leukemia.